[Federal Register Volume 63, Number 246 (Wednesday, December 23, 1998)]
[Notices]
[Pages 71156-71157]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-33882]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 4, 1998, Irix 
Pharmaceuticals, Inc., 101 Five Star Way, Florence, South Carolina 
29501, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of methylphenidate (1724), a 
basic class of controlled substance listed in Schedule II.
    The firm place to manufacture methylphenidate for demonstration 
purposes and for dosage form development and stability studies.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representatives 
(CCR), and must be filed no later than February 22, 1999.


[[Page 71157]]


    Dated: December 10, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-33882 Filed 12-22-98; 8:45 am]
BILLING CODE 4410-09-M